Exploring Key Insights of the Patient Controlled Injectors Market: Growth Prospects, Emerging Trends, and Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the patient controlled injectors market grown in recent years?
The market size for patient controlled injectors has expanded swiftly in the previous years. The market valuation is projected to rise from $4.51 billion in 2024 to $5.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.1%. The impressive growth recorded in the historic period can be ascribed to the burgeoning home healthcare sector, development of healthcare infrastructure, an uptick in diabetes cases, higher occurrence of infectious diseases, along with heightened attention towards personalized medicine.
How is the patient controlled injectors market size expected to evolve during the forecast period?
S2: Predictions for the patient controlled injectors market size reflect a significant surge in the coming years. Market value is expected to reach $8.25 billion in 2029, with a compound annual growth rate (CAGR) of 12.8%. The forecasted growth for this period is due to factors such as an increase in the elderly population, rising occurrence of chronic respiratory disorders, a significant upturn in chronic illness rates, increasing cancer diagnoses, and a proliferation of autoimmune diseases. Key trends projected during this period consist of technological evolution, including the integration of artificial intelligence, telemedicine and remote monitoring, advancements in portable devices and wearables, and an emphasis on minimally invasive procedures.
Get your patient controlled injectors market report here!
https://www.thebusinessresearchcompany.com/report/patient-controlled-injectors-global-market-report
Which key drivers are propelling the patient controlled injectors market’s growth?
The patient-controlled injectors market is forecasted to expand due to a predicted increase in chronic diseases. Chronic diseases are long-term health conditions that last for at least three months and often progress over time. The surge in these diseases can be attributed to various factors such as an aging population, obesity becoming more rampant, socioeconomic conditions, and exposure to certain environments. Patient-controlled injectors offer the advantage of allowing individuals to administer their medications accurately, conveniently, and according to a schedule that suits their treatment strategy. For example, the National Center for Biotechnology Information (NCBI), a U.S.-based medical database, predicted in January 2023 that by 2050, the number of people aged 50 and above with one or more chronic diseases is set to rise by 99.5% from 71.52 million in 2020 to 142.66 million. Hence, this uptick in chronic disease prevalence is anticipated to fuel the growth of the patient-controlled injectors market.
What are the market segments in the patient controlled injectors industry?
The patient controlled injectors market covered in this report is segmented –
1) By Product: Electronic Wearable Injector, Mechanical Wearable Injector, Infusion Pumps
2) By Application: Cancer Treatment, Auto-Immune Treatment, Blood Disorder Treatment, Other Application
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies
Subsegments:
1) By Electronic Wearable Injector: Pre-Filled Electronic Wearable Injectors, Programmable Electronic Wearable Injectors, Smart Electronic Wearable Injectors, Rechargeable Electronic Wearable Injectors, Bluetooth-Enabled Electronic Wearable Injectors, Disposable Electronic Wearable Injectors
2) By Mechanical Wearable Injector: Spring-Loaded Mechanical Wearable Injectors, Piston-Based Mechanical Wearable Injectors, Auto-Injectors (Mechanical), Manual Mechanical Wearable Injectors, Disposable Mechanical Wearable Injectors
3) By Infusion Pumps: Disposable Infusion Pumps, Programmable Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Large Volume Infusion Pumps, Implantable Infusion Pumps
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16759&type=smp
Which leading companies are shaping the growth of the patient controlled injectors market?
Major companies operating in the patient controlled injectors market are Medtronic plc, Becton Dickinson and Company, West Pharmaceutical Services, SCHOTT AG, Gerresheimer AG, Phillips-Medisize, Vetter Pharma-Fertigung GmbH & Co. KG, Stevanato Group, Ypsomed AG, Nemera, B. Braun Melsungen AG, Elcam Medical, Owen Mumford, Bespak, Unilife Corporation, Crossject, SHL Group, AptarGroup Inc., Credence MedSystems, Weibel CDS AG, Sorrel Medical
What emerging trends are influencing the growth of the patient controlled injectors market?
Leading businesses in the patient-controlled injectors market are creating unique products, such as ready-to-use syringes, to better cater to the customers with improved features. Prefilled, sterilized syringes with a fixed dosage of medication are referred to as ready-to-use syringes. These eliminate the requirement for manual preparation thereby minimizing the chances of contamination and dosage mistakes. For instance, Ypsomed AG, a medical equipment manufacturer based in Switzerland, introduced a new autoinjector platform specifically for liquid pharmaceuticals. The range for the capacity of these is between 1.5 to 5.5 ml. This newly introduced device is designed ergonomically to facilitate ease of use, and to ensure patients are comfortable during injections. Built-in safety mechanisms to avoid unintended needle pricks are part of the device’s features. Also, it gives visual and audio feedback to signify that the medication has been successfully delivered. Moreover, the autoinjector can work with various viscosities, signifying its wide-ranging suitability for therapeutic uses.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16759
Which geographic areas are influencing the growth of the patient controlled injectors market?
North America was the largest region in the patient controlled injectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient controlled injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Autoinjectors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/autoinjectors-global-market-report
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2019
https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market
Veterinary Patient Monitoring Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
